Induction of Mucosal Cellular Immunity by HIV-1 Vaccine Vectors
Induction of Mucosal Cellular Immunity by HIV-1 Vaccine Vectors
批准号:
7756350
负责人:
David Ross Kaufman
金额:
$12.66万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2014-05-31
关键词:
AccountingAcquired Immunodeficiency SyndromeAdenovirusesAnatomyApplications GrantsAscaridilCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCellular ImmunityDendritic CellsDiseaseEventGoalsHIVHIV InfectionsHIV vaccineHIV-1 vaccineHomingImmuneImmune responseIndividualIntestinal MucosaIntramuscularLymphocyteMacaca mulattaMediatingMemoryMolecularMucosal ImmunityMusPatternPhenotypePropertyRecombinantsShapesSignal TransductionSiteSpecificitySurfaceT-LymphocyteTestingTretinoinVaccinationVaccinesVirusWorld Health Organizationdesignmigrationmucosal vaccinepathogenprophylacticresponsetraffickingtransmission processvaccine developmentvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by candidate): The ability to generate potent mucosal cellular immune responses is an important goal of vaccine development. Mucosal immunity may be particularly critical in the setting of HIV infection, not only because transmission generally occurs at mucosal surfaces but because CD4+ T-lymphocytes in the intestinal mucosa are targeted preferentially for destruction early in the course of disease. However, the specific properties of a vaccine required to generate potent mucosal cellular immunity are not known. A better understanding is needed of the molecular mechanisms by which the lymphocyte priming milieu and mucosal microenvironments shape vaccine-elicited mucosal cellular immune responses. We hypothesize that vaccine-elicited cellular immune memory at mucosal surfaces is shaped both by the anatomic and molecular properties of the initial priming milieu and subsequent signals from mucosal microenvironments that dynamically reprogram T-lymphocyte homing specificity and phenotype. We propose to test this hypothesis with the following three Specific Aims: 1. To determine the key anatomic and molecular events that confer mucosal homing capacity on CD8+ T-lymphocytes following systemic vaccination; 2. To assess how systemic and mucosal microenvironments impact the differentiation of vaccine-activated CD8+ T-lymphocytes; 3. To evaluate the ability of mucosal dendritic cells and retinoic acid to reprogram the homing specificity of vaccine-elicited CD8+ T-lymphocytes.
RELEVANCE: HIV infects over 40 million individuals worldwide. According to recent World Health Organization estimates, over 2 million people become infected with HIV each year and a similar number die from complications of AIDS. Therefore, a prophylactic HIV vaccine is urgently needed. Because HIV transmission generally occurs at mucosal surfaces and the virus preferentially targets mucosal CD4+ T- lymphocytes for destruction, a vaccine that generates effective mucosal immunity is highly desirable.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Induction of Mucosal Cellular Immunity by HIV-1 Vaccine Vectors
-
批准号:7881690
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2009
-
负责人:David Ross Kaufman
-
依托单位:
海外基金